170 Nucleic Acid Delivery

Monday, November 14, 2016: 12:30 PM - 3:00 PM
Continental 8 (Hilton San Francisco Union Square)
Successful translation of nucleic acid therapies into the clinic hinges on efficient delivery into the desired sub-cellular compartment. Achieving this goal of intracellular delivery requires understanding and overcoming a multitude of biological barriers. As such, this session seeks to explore topics associated with (but not limited to) fundamental studies on key extracellular/intracellular pathways, trafficking of delivery vehicles, and design and development of novel carriers, in order to overcome biological barriers resulting in high efficacies of nucleic acid treatments in vitro and in vivo.

Engineering Fundamentals in Life Science
Biomaterials (08B)

Kaushal Rege
Email: krege@asu.edu

Christopher A. Alabi
Email: caa238@cornell.edu

12:30 PM
(170a) Fast, Efficient and Gentle Transfection of Human Adherent Cells in Suspension
Pranav Agrawal, Nilesh P. Ingle, William S. Boyle, Emily Ward, Jakub Tolar, Kevin D. Dorfman and Theresa M. Reineke

1:06 PM
(170c) Enhancement of Gene Therapy Via Inhibition of the Innate Immune Response
Jacob Elmer, Christine Muzzelo, Spivack Kyle, Butchy Adam and Christopher Neely

1:24 PM

2:00 PM
(170f) Combinatorial Treatment Using Lipopolymer-Mediated TRAIL Gene Delivery and Kinase Inhibitors for Bladder Cancer
Sheba Goklany, Sudhakar Godeshala, Matthew Christensen, Ping Lu, Elizabeth Elizabeth Garrett-Mayer, Christina Voelkel-johnson and Kaushal Rege
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division